HANG SENG BANK(00011)

Search documents
格隆汇公告精选(港股)︱荣昌生物(09995.HK):泰它西普(商品名:泰爱®)治疗原发性乾燥综合征中国III期临床研究达到主要终点
Ge Long Hui· 2025-08-14 14:59
Group 1: Core Insights - Rongchang Biologics (09995.HK) announced that its innovative drug Taitasip (brand name: Tai Ai®) for treating primary Sjögren's syndrome has met the primary endpoint in a Phase III clinical trial in China [1] - Taitasip is the first BLyS/APRIL dual-target fusion protein drug to complete Phase III research in the field of Sjögren's syndrome globally [1] - The clinical trial was a multi-center, randomized, double-blind, placebo-controlled study aimed at evaluating the efficacy and safety of Taitasip, with the primary endpoint being the change in ESSDAI score at week 24 compared to baseline [1] Group 2: Disease Background and Drug Mechanism - Sjögren's syndrome is a chronic inflammatory autoimmune disease characterized by lymphocytic infiltration and damage to exocrine glands, leading to persistent dry mouth and dry eyes, and can affect multiple organ systems [2] - The prevalence of Sjögren's syndrome in China is estimated to be between 0.3% and 0.7%, with an increasing trend indicating a significant unmet clinical need [2] - Taitasip is a novel dual-target fusion protein developed by the company that simultaneously inhibits the overexpression of BLyS and APRIL, effectively preventing abnormal differentiation and maturation of B cells [2] Group 3: Regulatory and Clinical Recognition - Taitasip has received multiple authoritative guideline recommendations in China, including the "Clinical Practice Guidelines for Sjögren's Syndrome" and the "Expert Consensus on B-cell Targeted Therapy for Rheumatic and Immune Diseases" [2] - Internationally, Taitasip has been granted Fast Track designation by the U.S. FDA for its indication in Sjögren's syndrome and has been approved to conduct global multi-center Phase III clinical trials [2]
恒生银行(00011.HK)8月14日回购2286.70万港元,已连续10日回购
Zheng Quan Shi Bao Wang· 2025-08-14 13:37
Core Viewpoint - Hang Seng Bank has been actively repurchasing its shares, indicating a strategy to support its stock price and enhance shareholder value [2] Summary by Category Share Buyback Activity - On August 14, Hang Seng Bank repurchased 200,000 shares at a price range of HKD 113.600 to HKD 115.400, totaling HKD 22.867 million [2] - Since August 1, the bank has conducted share buybacks for 10 consecutive days, acquiring a total of 2 million shares for a cumulative amount of HKD 228 million [2] - During this period, the stock price has increased by 0.34% despite the recent buyback activities [2] Stock Performance - The closing price of Hang Seng Bank on August 14 was HKD 113.700, reflecting a decrease of 0.87% for the day [2] - The total trading volume for the day was HKD 287 million [2] Detailed Buyback Data - The following table summarizes the buyback details for the past days: | Date | Shares Repurchased (thousand) | Highest Price (HKD) | Lowest Price (HKD) | Buyback Amount (thousand HKD) | |------------|-------------------------------|---------------------|--------------------|-------------------------------| | 2025.08.14 | 20.00 | 115.400 | 113.600 | 2286.70 | | 2025.08.13 | 20.00 | 115.800 | 114.400 | 2296.14 | | 2025.08.12 | 20.00 | 115.400 | 114.100 | 2300.02 | | 2025.08.11 | 20.00 | 116.200 | 115.100 | 2315.60 | | 2025.08.08 | 20.00 | 114.700 | 113.800 | 2286.94 | | 2025.08.07 | 20.00 | 115.100 | 113.200 | 2289.15 | | 2025.08.06 | 20.00 | 113.600 | 112.800 | 2263.47 | | 2025.08.05 | 20.00 | 114.200 | 113.100 | 2271.70 | | 2025.08.04 | 20.00 | 114.000 | 111.900 | 2267.19 | | 2025.08.01 | 20.00 | 114.300 | 112.400 | 2259.22 | [2]
恒生银行8月14日斥资2286.7万港元回购20万股
Zhi Tong Cai Jing· 2025-08-14 10:05
恒生银行(00011)发布公告,于2025年8月14日,该公司斥资2286.7万港元回购20万股。 ...
恒生银行(00011)8月14日斥资2286.7万港元回购20万股
Zhi Tong Cai Jing· 2025-08-14 10:04
智通财经APP讯,恒生银行(00011)发布公告,于2025年8月14日,该公司斥资2286.7万港元回购20万 股。 ...
恒生银行(00011.HK)8月14日耗资2286.7万港元回购20万股
Ge Long Hui· 2025-08-14 09:57
Group 1 - Hang Seng Bank announced a share buyback plan on August 14, 2025, involving an expenditure of HKD 22.867 million to repurchase 200,000 shares [1] - The buyback price range is set between HKD 113.6 and HKD 115.4 per share [1]
恒生银行(00011) - 翌日披露报表

2025-08-14 09:56
| 第一章節 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | | 00011 | 說明 | 股份 | | | | | | | 多櫃檯證券代號 | | 80011 | RMB 說明 | 股份 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | | | | | | 事件 | | 已發行股份(不包括庫存股份)數 目 | | 佔有關事件前的現有已發 行股份(不包括庫存股 份)數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | | 於下列日期開始時的結存(註1) | | 2025年8月13日 | | 1,882,267,536 | | 0 | | | 1,882,267,536 | | 1). 其 ...


大摩:港银中偏好估值合理的国际性银行 予汇丰控股(00005)及渣打集团(02888)“增持”评级
Zhi Tong Cai Jing· 2025-08-14 09:00
大摩认为,中银香港(02388)股息回报将获支持,相信即将公布的中期业绩当中净息差将受压,但非利 息收入预料表现强劲,将关注管理层对信贷质素及资本管理的看法,予"减持"评级,目标价从24.7港元 上调至31.4港元。该行又指,恒生银行(00011)估值偏高,维持减持评级,目标价由93港元升至94.5港 元。 智通财经APP获悉,摩根士丹利发布研报称,上半年本地利率因素及信贷质素风险持续,一众银行股中 较偏好国际银行多于本地银行,因本地银行估值偏高,而国际性银行估值相对合理、资本回报具支持及 前景正面,维持对汇丰控股(00005)及渣打集团(02888)的"增持"评级。 (原标题:大摩:港银中偏好估值合理的国际性银行 予汇丰控股(00005)及渣打集团(02888)"增持"评 级) 该行认为,银行股第二季业绩将主要受HIBOR下跌及香港商业地产信贷质素恶化的影响,预料财富管 理业务及市场收入可抵销部分压力,但相信下半年挑战仍存在,预计银行净利息收入及净息差将于第三 季录得按季下跌,至第四季有望轻微复苏。随着美国利率预期下降,大摩预期2026年净息差可进一步收 窄。 ...
7家港股公司回购 恒生银行回购2296.14万港元





Zheng Quan Shi Bao Wang· 2025-08-14 01:49
Group 1 - On August 13, seven Hong Kong-listed companies conducted share buybacks, totaling 1.8705 million shares and an amount of 45.2591 million HKD [1][2] - The company with the highest buyback amount on August 13 was Hang Seng Bank, which repurchased 200,000 shares for 22.9614 million HKD, with a year-to-date total buyback amount of 205.49 million HKD [1][2] - MGM China repurchased 1 million shares for 15.9846 million HKD, with a year-to-date total buyback amount of 86.6466 million HKD [1][2] Group 2 - The buyback prices for Hang Seng Bank ranged from a maximum of 115.800 HKD to a minimum of 114.400 HKD [1][2] - For MGM China, the buyback prices ranged from a maximum of 16.070 HKD to a minimum of 15.870 HKD [1][2] - FIH Mobile Limited (富智康集团) repurchased 211,000 shares for 3.1187 million HKD, with a year-to-date total buyback amount of 34.4219 million HKD [1][2]


智通港股回购统计|8月14日





智通财经网· 2025-08-14 01:13
Group 1 - The companies that conducted share buybacks on August 13, 2025, include Hang Seng Bank, MGM China, FIH Mobile, Yuan Zheng Technology, North Forest Holdings, and International Home Retail [1] - Hang Seng Bank had the largest buyback amount, repurchasing 200,000 shares for a total of 22.96 million [1] - The total number of shares repurchased by Hang Seng Bank in the year reached 1.8 million, accounting for 0.096% of its total share capital [2] Group 2 - MGM China repurchased 1 million shares for a total of 15.98 million, with a year-to-date total of 5.63 million shares, representing 0.148% of its total share capital [2] - FIH Mobile repurchased 211,000 shares for a total of 3.12 million, with a year-to-date total of 2.95 million shares, representing 0.374% of its total share capital [2] - North Forest Holdings repurchased 20,000 shares for a total of 1.66 million, with a year-to-date total of 6.19 million shares, representing 0.881% of its total share capital [2] - Yuan Zheng Technology repurchased 107,500 shares for a total of 1.40 million, with a year-to-date total of 1.70 million shares, representing 1.054% of its total share capital [2] - International Home Retail repurchased 150,000 shares for a total of 0.13 million, with a year-to-date total of 3.57 million shares, representing 0.493% of its total share capital [2] - Meiheng Industrial repurchased 2,000 shares for a total of 0.90 million, with a year-to-date total of 3.57 million shares, representing 0.870% of its total share capital [2]

佰悦集团(08545)股东将股票存入恒生银行 存仓市值262.20万港元
Zhi Tong Cai Jing· 2025-08-14 00:41
Core Viewpoint - The company, Baiyue Group, is expected to report a significant loss for the current fiscal year, primarily due to a substantial decline in revenue across its toy business segments, attributed to economic pressures and reduced consumer spending on non-essential items [1] Financial Performance - As of June 30, the company anticipates a loss attributable to shareholders of no less than 2 million HKD for the current fiscal year, compared to a profit of approximately 490,000 HKD for the previous fiscal year ending March 31, 2024 [1] - Revenue is projected to decrease by about 34.7%, significantly impacting the company's financial performance [1] Business Segments - Sales of ODM toys to licensed holders and the company's own licensed toys and related products have decreased by 46.5% and 40.4%, respectively [1] - The decline in sales is primarily due to economic pressures, including inflation and a reduction in consumer spending on non-essential goods [1] Impairment Loss - The company has recognized an impairment loss of 4.5 million HKD related to its equity interest in an associate company, which is facing operational challenges due to economic downturn, increased competition, and operational difficulties [1]